Partnership with GE Healthcare Sends iCAD Shares Soaring
Last week GE Healthcare announced would it would be incorporating iCAD’s SecondLook technology into its line of Senographe Full-Field Digital mammography systems. iCAD shares opened […]
News
EndoBarrier: An Endoscopic Alternative to Gastric Bypass
With 3000 calories and 229 grams of fat in the average Thanksgiving Day meal (just the meal itself!) – the morbidly obese may soon be […]
More Good News from Aethlon, Hemopurifier Reverses Immune Suppression in Cancer Patients
Aethlon’s prospects seem to be growing brighter by the minute. Last week I reported that the company had initiated a research collaboration to study the […]
Kensey Nash Delivers OsseoFit, Further Strengthening its Biomaterials Division
Kensey Nash announced the first commercial shipment of its OsseoFit Porous Tissue Matrix to Biomet Sports Medicine, the sports medicine subsidiary of Biomet Inc. The […]
Aethlon Medical to Study Effectiveness of Hemopurifier in Treating HIV
Aethlon Medical has initiated a research collaboration to study the in vitro effectiveness of the Aethlon Hemopurifier to clear HIV from blood. The studies, being […]
Four Cases of HIV Transmission May Dictate Use of the Nucleic Acid Amplification Test
The Tribune reported yesterday that four transplant recipients in Chicago have contracted HIV and hepatitis C from an organ donor. It is the first time […]
Best Practice Web Design in the Healthcare Industry
A website is a critical component of any medical device company, not only because patients use them to learn about new or innovative cures, but […]
Regeneration Technologies, Tutogen Medical to Form Implant Powerhouse
Regeneration Technologies and Tutogen Medical have approved a definitive agreement to merge the two companies in a tax-free, stock-for-stock exchange. The combined entity will be […]
AngioDynamics’ RFA Shows Promise for Patients with Unresectable Liver Metastases
A recent study conducted by Dr. Allan Siperstein and colleagues at the Cleveland Clinic presented three and five year survival data following radiofrequency ablation of […]
Abbott Refutes Conclusions Reached by Wachovia Analyst Larry Biegelsen
Following an October 11th downgrade of Abbott Laboratories to market perform, Wachovia released further negative reports related to Abbott’s Navigator Continuous Glucose Monitor. Abbott won […]